Study Supports Migraine Procedure Technology

(c) Can Stock Photo

July 22, 2014

Is someone you care about suffering with migraines and thinking about undergoing a migraine procedure to treat their chronic migraine? If so, you may want to share this latest medical research news that suggests another good reason to learn more about how the Omega™ migraine procedure can help someone with debilitating chronic migraine enjoy his or her life again.

A recent Medscape news article, about a study performed by a neurologist and her team at the Thomas Jefferson University in Philadelphia, reported that chronic migraine is better treated by stimulating both the supraorbital and occipital nerves, rather than by only stimulating the occipital nerve. The Omega™ migraine procedure similarly, works by stimulating both areas in the head.

The research findings were presented at the 82nd Annual Meeting of the American Association of Neurological Surgeons. Of the 20 subjects with chronic headaches who were tested, 14 reported more than a 50 percent improvement in their headache symptoms after dual stimulation. The neurologist said this was an improvement over the results recorded after single-location stimulation.

During the initial trials, the 20 subjects all reported an improvement after stimulation. The good news remained consistent at follow-up, which averaged 34 months after the initial migraine procedure implanting the stimulators.   Of the 9 subjects who took prescription pain medication, 5 were able to discontinue their drugs.

Of the 14 subjects with at least a 50 percent improvement, 9 patients indicated their improvement was greater than 80 percent. The researchers noted the study was promising but that more research would be beneficial.

While these results are preliminary, the outlook for chronic migraine sufferers is promising. The Omega™ migraine procedure is not only well established, and backed with substantial published research, it has a 80-90 percent success rate for certain migraine sufferers. It also allows for neurostimulation to either or both the occipital and supraorbital nerves. Good news to know!




Previous post:

Next post: